Company A Value Of Investments

A company listed in2000in Shanghai stock market. Depended on fund whichcame from the market, A company made big investment to improve technologies andaccumulate projects experience, already got technical advantage of production for”Semi synthesis-Fermentation”, and optimized products structure. Currently, Acompany is the biggest material provider in the country for Antitumor drug,cardiovascular agents, etc. As a market leader, company A persists in healthy growingwith globalization, including transfer API’s production line, export preparation, andregistered in drug administration earlier than other competitors. Pharmaceuticalindustry has a high profession threshold, so many investors cannot understand thecompany well, but as a Sunrise industry always, increasing investors focus on themarket since it have the characteristics with high growing defense. The paperintroduces and analyzes investment value for company A.There are six chapters in the paper. Chapter I introduce the historicaldevelopment, ownership structure, business/product introduction of the company.Chapter II is the Chinese and World medicine profession analysis. It introducespresent medicine profession situation, profession characteristic, and existencequestion and so on. Chapter III is the financial analysis. It mainly takes2008~2010year annual reports to analyzes and evaluate the company. Chapter IV is the SWOTanalysis. It analyzes the company from strength, weakness, opportunity and challenge.Chapter V is the evaluation. It uses DDM, PE, PB, PS to evaluate the company, andgive a value sector. Chapter VI is the investment risk analysis. It analyze from thepolicy change risk, the drugs security risk, the profession competition risk and thestock market risk. Finally, we will give a conclusion for the investment risk ofcompany A. After researching, it shows that company A has the investmentopportunity.